Navigation Links
Impact Of Late Motherhood on Children

Statistics from the Human Fertilization and Embryology Authority show that recently there is a surge in the number of patients opting for assisted reproduction technology// (ART) in the UK. It is astonishing to know that the average age of these women is 34. There is increase in women choosing to delay parenthood and subsequently seeking treatment for infertility. The doctors and scientists say that there are long-term risks associated to elderly mothers and their babies. But the elderly mothers say that they are healthier and fitter than many younger women.

But the clinicians say that their ageing eggs result in increased risks of chromosomal abnormalities in the offspring. The other problems added to late pregnancies are increased risk and difficulty to conceive, subsequent pregnancy loss, increased risk of problems such as diabetes, high blood pressure, heart problems, deep vein thrombosis and operative delivery. But these late mothers forget the chances of they dying before their children reach maturity and the near impossibility of providing the child with grandparents or contemporary siblings. The shortage of donors in the UK reveals the fact that many women go abroad and poor women in Eastern Europe are being exploited by foreign clinics. Most women pay only for their ART treatment. Hence the welfare of both the mother and the child should be kept in mind before taking any decision.


'"/>




Page: 1

Related medicine news :

1. Impact on Lung function based on exposure
2. Personality Impacts Arthritis
3. Support Services found to Dramatically Impact Pediatric Health Care
4. The Impact of Stress Early In Life
5. Environmental Factors Found To Have An Impact On The Sex of A Child
6. Environmental Factors Found To Have An Impact On The Sex of A Child
7. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
8. Earth Will Feel The Impact Of Global Warming
9. Obesity Has Adverse Impact On Breast Cancer Survival
10. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
11. Impact Of Stress On Belfast Males
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Impact Late Motherhood Children

(Date:12/6/2009)... factor, researchers say , , SUNDAY, Dec. 6 (HealthDay ... the main tumor to other parts of the body ... which may prove a promising target for new drugs ... Previous studies have shown that TGFb (transforming growth factor ... new study, a team from Cancer Research UK used ...
(Date:12/6/2009)... -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Phase 2b 003-A1 study, known as the 003 ... pre-treated relapsed and refractory multiple myeloma patients. These ... Symposium at the 51st annual meeting of the ... Enrollment in this trial is complete (n=269), and ...
(Date:12/6/2009)... 6, 2009 A new study provides welcome news ... venous thromboembolism (VTE). , The condition is estimated ... and occurs when an abnormal clot forms in a ... and swelling. In some cases, the clot may detach ... heart to the lungs, causing a potentially fatal condition ...
(Date:12/6/2009)... & Fox, LLP says dangerous substances such as asbestos have been ... ... New York, NY (PRWEB) December 6, 2009 -- As parents shop ... to reports of recalls due to lead paint or asbestos contamination, ... children visit hospital emergency rooms each year due to toy-related injuries,” ...
(Date:12/5/2009)... Cuts for a Cause ,, Why: ... other terminal illnesses affecting children. All proceeds from each hair ... Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, provided ... Falls Church for all guests. Hoa Lai, a DJ known ...
Breaking Medicine News(10 mins):Health News:Breast Cancer's Spread Now Better Understood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3
... on the surface of cancer cells are keys to ... treating and stopping the spread of certain types of ... lung, among others. Armed with a new two-year ... an Illinois-based philanthropic foundation, immunologist Alessandra Franco, M.D., Ph.D., ...
... , , THURSDAY, Jan. 8 (HealthDay News) -- Many people ... new Canadian study says. , Sixty-three percent of study ... for an experiment with a white person rather than a ... about the black person when he left the room. ...
... CHICAGO, Jan. 8 Allscripts-Misys Healthcare,Solutions, Inc., formerly ... announced its financial results for the three and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ) , ... three and six months ended November 30, 2008,include ...
... educational Web site offers expert perspectives, advice and ... from the Agency for Healthcare Research and Quality,s ... a federally sponsored network of more than a ... Health Advisory Information Network ( CHAIN ) ...
... HSKA ) announces the following Webcast: , What: ... Year-End 2008 Earnings Conference Call on the Web, ... Where: www.heska.com (click on the Q4 and Year-End 2008 Earnings, ... the front page of this website)., How: Live ...
... StrikesNEW YORK, Jan. 8 United Jewish Communities (UJC) ... to raise $10 million to address humanitarian and social ... to support and stand in solidarity with Israelis during ... control of the Gaza Strip. The funds will enhance ...
Other Medicine News:Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Many Turn Blind Eye to Racism 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2
(Date:12/4/2009)... MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging ... in Marlton, New Jersey continues to provide superior ... thyroid, dental, TMJ and sinus regions to assist ... these areas. ,, Thermography utilizes infrared imaging ...
(Date:12/4/2009)... ,, PHILADELPHIA, Dec. 4 Teamster members employed ... are hard at work educating the public about the ... put Philadelphia,s blood supply at risk. More than ... picket line yesterday when their issues were ignored by ...
(Date:12/4/2009)... Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ... investor teleconference and webcast. Principal investigators will discuss ... multiple myeloma, as featured at the 51st American Society ... begin at 9:00 a.m. CT/10:00 a.m. ET on Monday, ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 1Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 2Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 3Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 4Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 5Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 6Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 7Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 8Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 9Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 10Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 11Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 12Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 13Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 14The Minnesota Nurses Association 3A School Nurses in Minnesota Celebrate 100 Years of Addressing Health Needs of School Children 60726 1The Minnesota Nurses Association 3A School Nurses in Minnesota Celebrate 100 Years of Addressing Health Needs of School Children 60726 2United States Intervenes in False Claims Act Suit Against Virginia Medicaid Providers 60721 1United States Intervenes in False Claims Act Suit Against Virginia Medicaid Providers 60721 2
... N.J., May 7 Johnson & Johnson,will provide ... May 9,at 4:00 p.m. (Eastern Time) to coincide ... Tampa, Fla. Phase 3 clinical data presentations on,investigational ... analgesic, will be presented for the first time ...
... Individualized Treatment for ... Schizophrenia, ... VNDA ) investigational drug candidate,iloperidone, included its 4-week, short-term Phase ... trials, studying the efficacy,and safety of iloperidone. Iloperidone is a 5HT2/D2 ...
Other Medicine Technology:Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7
... Electronic Medical Record system. It stores patient chart ... and everything you would normally put in a ... Someone has to write them, file them, find ... Paper Charts get lost. They find their way ...
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% is the first and only therapy for patients with keratoconjunctivitis sicca (Dry Eye Disease) whose tear production is presumed to be supressed d...
... The ORK WAVEFRONT ANALYZER ... the aberrations of the entire ... ability to analyze aberrations in ... of sphere, cylinder, higher order ...
... eye drops quickly remove redness ... other pollutants and provide protection ... and the sun. This unique ... LIQUIFILM®, to soothe, cool and ...
Medicine Products: